Loading...
Our stats2018-12-01T21:46:34+00:00

Key statistics on our positive impact

Transactions:

  • ~2 billion transactions in 2017

In workflow: Our impact in workflow

  • > 300,000 prescribers reachable in their EHR (60% of prescribers in ambulatory care)
  • In 2018, NRxs written in the ConnectiveRx EHR network are expected to account for ~25% of IQVIA (formerly IMS) NRxs
  • In 2018, NRxs written in the ConnectiveRx EHR network are expected to account for 1 in 3 eRxs
  • > 150 million patients reachable in their prescriber’s office via EHR
  • Collaborate with EHR partners representing ~ 400 of the 500 certified EHRs

Reach:Our impact on digital / direct reach

  • > ~ 900,000 prescribers reachable via email (722,000 MDs / DOs + 177,000 NPs / PAs = 899,000 prescribers)
  • > 76,000 pharmacists reachable via email
  • > 1.5 million HCPs reachable (via all channels including direct mail)

Pharmacies: Our impact in Pharmacies

  • ~ 60,000 pharmacies adjudicate ConnectiveRx copay programs
  • > 16,000 pharmacies in communications network
  • ~ 55,000 pharmacists reachable in dispensing workflow
  • In 2017, reached over 59 million patients at the point of dispensing (pharmacy)
  • In 2017, pharmacies in the ConnectiveRx network dispensed 17% of retail-dispensed TRxs

Claims: Our impact on claims

  • ~ 870,000 prescribers have used ConnectiveRx copay services (since 2005)
  • > 108 million unique claims processed (since 2005)
  • In 2017, adjudicated over 17 million Rxs in savings programs
  • Have run copay programs for 571 brands

Authorization: Our impact on authorizations

  • Benefit investigation (BI) turnaround (pharmacy): 95% within 4 hours
  • BI turnaround (medical): 95% within 8 hours
  • Overturning denied claims or PAs: approaching 80%
  • Average speed to answer (phone, live chat): under 20 seconds

Transactions:

  • ~2 billion transactions in 2017

In workflow: Our impact in workflow

  • > 300,000 prescribers reachable in their EHR (60% of prescribers in ambulatory care)
  • In 2018, NRxs written in the ConnectiveRx EHR network are expected to account for ~25% of IQVIA (formerly IMS) NRxs
  • In 2018, NRxs written in the ConnectiveRx EHR network are expected to account for 1 in 3 eRxs
  • > 150 million patients reachable in their prescriber’s office via EHR
  • Collaborate with EHR partners representing ~ 400 of the 500 certified EHRs

Reach: Our impact on digital / direct reach

  • > ~ 900,000 prescribers reachable via email (722,000 MDs / DOs + 177,000 NPs / PAs = 899,000 prescribers)
  • > 76,000 pharmacists reachable via email
  • > 1.5 million HCPs reachable (via all channels including direct mail)

Pharmacies: Our impact in Pharmacies

  • ~ 60,000 pharmacies adjudicate ConnectiveRx copay programs
  • > 16,000 pharmacies in communications network
  • ~ 55,000 pharmacists reachable in dispensing workflow
  • In 2017, reached over 59 million patients at the point of dispensing (pharmacy)
  • In 2017, pharmacies in the ConnectiveRx network dispensed 17% of retail-dispensed TRxs

Reach:Our impact on digital / direct reach

  • ~ 870,000 prescribers have used ConnectiveRx copay services (since 2005)
  • > 108 million unique claims processed (since 2005)
  • In 2017, adjudicated over 17 million Rxs in savings programs
  • Have run copay programs for 571 brands

Authorization: Our impact on authorizations

  • Benefit investigation (BI) turnaround (pharmacy): 95% within 4 hours
  • BI turnaround (medical): 95% within 8 hours
  • Overturning denied claims or PAs: approaching 80%
  • Average speed to answer (phone, live chat): under 20 seconds